Hofheinz, R., Willer, A., Weißer, A., Gnad-Vogt, U., Saußele, S., Kreil, S., . . . Hochhaus, A. (2004). Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer. British journal of cancer, 90(10), . https://doi.org/10.1038/sj.bjc.6601786
Chicago-Zitierstil (17. Ausg.)Hofheinz, Ralf-Dieter, Andreas Willer, Andreas Weißer, Ulrike Gnad-Vogt, Susanne Saußele, Sebastian Kreil, Jörg Thomas Hartmann, Rüdiger Hehlmann, und Andreas Hochhaus. "Pegylated Liposomal Doxorubicin in Combination with Mitomycin C, Infusional 5-fluorouracil and Sodium Folinic Acid. A Phase-I-study in Patients with Upper Gastrointestinal Cancer." British Journal of Cancer 90, no. 10 (2004). https://doi.org/10.1038/sj.bjc.6601786.
MLA-Zitierstil (9. Ausg.)Hofheinz, Ralf-Dieter, et al. "Pegylated Liposomal Doxorubicin in Combination with Mitomycin C, Infusional 5-fluorouracil and Sodium Folinic Acid. A Phase-I-study in Patients with Upper Gastrointestinal Cancer." British Journal of Cancer, vol. 90, no. 10, 2004, https://doi.org/10.1038/sj.bjc.6601786.